SHSE •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSHSE
Market Capitalization2,834.38 mln
Float54.53 mln
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-1.76
Likely manipulated
Relative Strength
95
/ 100
Top performer
Debt / Equity
0.55
Moderate leverage
Pre-Tax Margin
-11%
Loss-making
ROE
-6.07
Negative
Business Description
Founded in 1998 and based in Taizhou, China, Zhejiang East Asia Pharmaceutical manufactures and sells a wide range of medicines, including antibiotics, antifungals, antiviral drugs, cancer treatments, and medications for the heart, digestive system, nervous system, and respiratory conditions. The company distributes its products to customers across Japan, South Korea, Europe, the Americas, Southeast Asia, and other international markets.
